African Bundibugyo Ebola Vaccine Candidate Advances to Human Trials
The Coalition for Epidemic Preparedness Innovations (CEPI) has awarded up to US$16.5 million to the Minapharm Group to advance a Bundibugyo ebolavirus vaccine candidate into a Phase 1 clinical trial ... Read More